galapagospharma

Our ambition is to apply groundbreaking science and accelerate innovation in immunology and oncology to transform the lives of patients globally and give them ...

We are scientists, entrepreneurs, and pioneers united around a single purpose: to transform patient outcomes through life-changing science and innovation ...

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations ...

Galapagos NV · 成交40.71 · 開盤40.77 · 最高41.01 · 最低40.5 · 一年內最高48.07 · 買進40.12 · EPS (TTM)-2.58 · PE Ratio(TTM). - ...

Galapagos is a global biotechnology company with operations in Europe and the US dedicated to developing transformational medicines for more years of life ...

Galapagos Global. Galapagos NV Generaal de Wittelaan 2800 Mechelen, Belgium. Tel: +32 15 34 29 00. Fax: +32 15 34 29 01. VAT BE 0466.460.429. Legal Entity ...

With CellPoint and AboundBio, Galapagos gained access to a scalable, decentralized and automated point-of-care cell therapy supply model, a clinical pipeline in ...

2023年11月28日 — At Galapagos, we organize clinical trials in various therapeutic areas, conducting research that paves the way for innovative solutions. Visit ...

Press Releases. This section contains information about Galapagos NV's business for stockholders, potential investors, financial analysts and media.

For medical information inquiries regarding Galapagos products in Great Britain and Northern Ireland: 0800 072 7878. Contact us. Pharmacovigilance. Our ...